• SENSEX
    NIFTY 50
Healthcare

WHO pauses hydroxychloroquine trials citing safety concerns

Updated : May 26, 2020 04:51 PM IST

The trial halted as new Lancet study showed no benefit, higher risk of death and cardiac complications.
There are reportedly over 150 studies currently ongoing across the world on hydroxychloroquine and its use in COVID-19 treatment.
India recently expanded use of hydroxychloroquine as a preventive therapy for COVID-19.

You May Also Like

Live TV
Advertisement